4DMT (NASDAQ: FDMT) is a gene therapy company with a transformative discovery platform that enables its “disease first” approach to product discovery and development.

Abogen is a China-based clinical-stage biotechnology company advancing mRNA-based therapeutics for the treatment of cancer and infectious diseases, including COVID-19.

Affinia is an innovative gene therapy company focused on helping people affected by devastating rare and non-rare diseases.

Aktis is a US-based biotechnology company discovering and developing a novel class of targeted radiopharmaceuticals to treat a broad range of solid tumor cancers.

Alebund is a China-based clinical stage biopharmaceutical company dedicated to providing better clinical solutions to patients with kidney diseases and related chronic conditions.

Allorion Therapeutics is focused on developing novel small molecule drugs against cancer and autoimmune diseases with operations in both China and the US.

AnHeart Therapeutics is a global oncology-focused clinical stage biopharmaceutical company operating in both China and the US.

Arctic Vision is a China based clinical stage ophthalmology company focused on developing innovative therapies for pan-ocular disease.

ArriVent (NASDAQ: AVBP) is a US-based biopharma company dedicated to accelerating the global development of innovative biopharmaceutical products.

Bluejay is a US-based company whose mission is to develop innovative cures for infectious diseases with the first target indication of chronic HBV infection.

Biocytogen is an international biotechnology company with expertise spanning the entire process of new drug research and development.

Bioheng is a China-based clinical-stage biotechnology company  dedicated on developing novel cellular immunotherapy for cancer.

Century (NASDAQ: IPSC) is a US based leading cell therapy company utilizing iPSC to develop cell products with the potential to overcome the limitations of early autologous and allogeneic cell therapies.

Cullgen is a China based biopharmaceutical company dedicated to the treatment of diseases lacking effective therapeutic approaches.

EpimAb is a China-based clinical stage biotech company specializing in bispecific antibody development.

Everest Medicines (SEHK: 1952.HK) is a late clinical-stage biopharmaceutical company focused on licensing, developing and commercializing globally innovative therapies.

Forge is a US-based gene therapy company with a promising pipeline of disease-modifying AAV-based therapies to potentially help patients with rare genetic diseases.

Hanyu Medical is a China-based medical device company committed to the R&D and commercialization of innovative medical devices for structural cardiology.

Harbour BioMed (SEHK: 2142.HK) is a global, clinical stage biopharmaceutical company developing innovative therapeutics in the fields of immuno-oncology and immunological diseases.

HeMo is a China-based neurovascular interventional devices innovative platform enterprise.

Hummingbird is a Singapore-based clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets to improve treatment outcomes.

Immune-Onc is a US-based clinical-stage cancer immunotherapy company developing novel biotherapeutics targeting immunosuppressive myeloid checkpoints.

ImmVira is a China based biotechnology platform dedicated to the development of more effective and safer therapies against cancer.

Insight Lifetech is a China-based medical device company aiming to be a global leading manufacturer of interventional cardiovascular diagnostic and therapy products.

Sipai Health Technology is a China-based medical technology company leading the digital transformation of healthcare to bring quality and accessible care to everyone.

New Horizon Health (SEHK: 6606.HK) is a leader and a pioneer in home testing for a number of different types of cancers and is China’s first biotech company focusing on early cancer screening.

NiKang Therapeutics is an early stage biotech company focused on discovering and developing innovative small molecule oncology medicines to help patients with unmet medical needs.

Numab is a Switzerland-based biopharmaceutical company developing next-generation multispecific antibody-based immunotherapies for cancer and inflammation.

Omega (NASDAQ: OMGA) is a US-based development-stage biotech company pioneering the field of epigenomic programming to precisely regulate and control the human genome to treat and cure disease.

ProfoundBio is a US-based biotechnology company developing novel antibody-drug conjugate (ADC) therapeutics for patients with cancer.

SQ Medical is a China-based medical device enterprise focused on cardiovascular intervention, peripheral vascular intervention and structural heart disease.

Sonoma Biotherapeutics is leading the development of adoptive T-cell (Treg) therapies for autoimmune and degenerative diseases.

StrideBio is a US-based leading developer of novel engineered adeno-associated virus (AAV) based gene therapies.

Taysha Gene Therapies (NASDAQ: TSHA) is a patient-centric gene therapy company with a mission to eradicate monogenic CNS disease.

Vedere is a US-based company developing next generation ocular gene therapies designed for vision restoration and preservation.

Vera Therapeutics (NASDAQ: VERA) is a US based clinical-stage biotechnology company focused on developing treatments for immunological and inflammatory diseases.

Zylox (SEHK: 2190.HK) is a China-based medical device company focused on interventional and implantable peripheral vascular devices.